HCG takes major leap with acquisition of SRJ CBCC Cancer Hospital


Healthcare Global Enterprises Limited (HCG), India’s premier cancer care network, today unveiled its ambitious acquisition of the SRJ CBCC Cancer Hospital in Indore. This game-changing move fortifies HCG’s steadfast mission to render unparalleled cancer care throughout India. As part of its comprehensive expansion strategy, HCG aims to enhance the hospital’s infrastructure by adding 100 state-of-the-art beds and avant-garde cancer diagnostic and treatment facilities within the next two years. With this acquisition, HCG’s robust network encompasses 21 comprehensive cancer centers, 24 hospitals spread across India and Africa, and 8 Daycare centres.

Located at the heart of Indore, SRJ CBCC Cancer Hospital holds the distinction of being the city’s pioneer in comprehensive cancer care and currently dominates the private sector. Equipped with 50 specialized cancer care beds and the latest LINAC machine, this acquisition propels HCG to newer heights, opening doors for operational enhancements and the introduction of cutting-edge cancer care technologies.

See also  ONGC distributes solar chulhas in Betul district, Madhya Pradesh

Dr. B. S. Ajaikumar, Executive Chairman of Healthcare Global Enterprises Limited, enthusiastically remarked, “This acquisition is a testament to HCG’s unwavering dedication to world-class cancer care. We envision this move as a transformative step to positively impact countless lives and emphasize our commitment to superior cancer care across India. Coupled with the SRJ CBCC Cancer Hospital’s legacy of excellence, we’re poised to redefine oncology care in Indore and the adjoining regions.”

See also  Could Arvind Kejriwal's bold stand against in Madhya Pradesh land him in jail?

Echoing the sentiment, Raj Gore, CEO of Healthcare Global Enterprises Limited, emphasized, “Our expansion into Madhya Pradesh represents our earnest endeavor to bridge the cancer care gap. With this move into Indore, our focus is to provide unparalleled cancer treatment to patients, negating the need for them to travel great distances. Our extensive network of eminent oncologists and the country’s largest Tumor Board will now extend their expertise to Indore and Madhya Pradesh. Ensuring the best patient outcomes remains our top priority.”

See also  Rusan Pharma launches API facility in Pithampur SEZ, Madhya Pradesh

India grapples with a mounting cancer incidence burden, with Madhya Pradesh recording significant cases, especially in Head & Neck, Tongue cancers in men, and Breast and Cervix cancers in women. Since its inception in 1989, starting with its inaugural Cancer Centre in Bangalore, HCG has been at the forefront of pioneering cancer diagnostic and treatment protocols.

Known for its innovative methodologies, advanced diagnostic tools, and unparalleled patient outcomes, HCG has set the gold standard in cancer care. Their holistic approach, encompassing prevention, screening, diagnosis, treatment, rehabilitation, and palliative care, ensures that cancer patients in Indore and beyond receive the best care possible.

Share This